Hello!
By clicking, I accept the Terms of Services & Privacy Policy
Selling fast! 158 people have this in their carts.
We are rated 5 stars on Google
Trusted by our customers
Wegovy 0.25mg Injection contains Semaglutide, a medication used primarily to manage type 2 diabetes mellitus. It is a member of the group of medications called GLP-1 receptor agonists.
To prevent interactions, let your doctor know about any additional medications or supplements you use. If you get severe stomach pain or an allergic reaction, get help right away. Before using, women who are pregnant or nursing should speak with their doctor.
This Product is Out of Stock.
Click here to check delivery availability
Guarantee Safe
Checkout
Estimate delivery times: 5-7 days.
Return within 7 days of delivery.
Wegovy 0.25mg Injection contains Semaglutide, a medication used primarily to manage type 2 diabetes mellitus. It is a member of the group of medications called GLP-1 receptor agonists.
Brand Name: Wegovy
Composition: Semaglutide
The GLP-1 hormone, which is essential for controlling blood glucose levels, is mimicked by semaglutide. When blood sugar levels are high, it increases insulin secretion by inducing the pancreas to release more insulin. Semaglutide also inhibits the liver's production of glucagon, a hormone that causes blood sugar levels to rise. Additionally, it slows down the rate at which food exits the stomach by delaying gastric emptying, which helps curb appetite and manage post-meal glucose increases.
Type 2 Diabetes Mellitus
Weight Loss Management
Wegovy 0.25mg injection is easy to administer and comes in a prefilled pen for self-administration. To guarantee safe and efficient use at home, consult your physician or other healthcare professional about appropriate training for you or your caretaker.
Liver 
Patients with liver illness should use Wegovy with caution. Wegovy dosage adjustments might be required. Kindly speak with your healthcare provider.
Kidney Patients with renal illness should use Wegovy with caution. Wegovy dosage adjustments might be required. Kindly speak with your healthcare provider.
Pregnancy Animal studies suggest that Wegovy could be harmful to the fetus, so it may not be safe to use during pregnancy. Before using it, discuss benefits and risks with your healthcare provider.
Breast Feeding Using Wegovy while nursing is most likely dangerous. The medication may damage the developing baby if it enters the breastmilk, according to limited human data. Kindly speak with your healthcare provider.
Alcohol It is unknown if drinking alcohol while using Wegovy is unsafe. Kindly speak with your healthcare provider.
Store at cool temperature 2°C to 5°c. Keep in the original packaging to protect from moisture and light.
As prescribed, take this medication orally at the same time each day, right after waking up, and with no more than four ounces of plain water. After ingesting the tablets whole, wait at least half an hour before eating, drinking, or taking any other drugs.
With every prescription and refill, the pharmacist will provide you with a unique MedGuide. Every time, make sure to carefully read this information. Discuss the usage of this drug in children with your care team. Extra caution could be required.
1. Smits MM, Van Raalte DH. Safety of semaglutide. Frontiers in endocrinology. 2021 Jul 7;12:645563.
2. Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends in cardiovascular medicine. 2023 Apr 1;33(3):159-66.
3. Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I. Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine. 2023 Dec 14;389(24):2221-32.
4. Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Wharton S. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021 Mar 18;384(11):989-1002.
The main goal of Apothecare is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.
Name: Novo Nordisk India Pvt Ltd
Address: Plot No.32, 47-50, EPIP Area, Whitefield, Bangalore - 560 066
Country of origin: Denmark
Frequently Asked Questions:
1. What is Wegovy 0.25mg Injection?
Wegovy (Semaglutide) 0.25mg is the initial starting dose of a GLP-1 receptor agonist that may be prescribed as part of a chronic weight management programme in adults with obesity or overweight associated with weight-related health conditions. Its suitability must be assessed by a qualified physician.
2. How may Wegovy work for weight management?
Semaglutide is believed to mimic the GLP-1 hormone, which may:
• Help reduce appetite and food cravings in some patients
• Slow the rate of gastric emptying
• Promote a feeling of fullness
• Assist in regulating blood sugar levels
The degree of these effects may vary considerably between individuals.
3. Who may be eligible for Wegovy?
Wegovy may be considered for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as Type 2 diabetes, hypertension, or dyslipidaemia. Eligibility is determined by your physician after a thorough clinical assessment.
4. Why is treatment started at 0.25mg?
The 0.25mg starting dose is intended to allow the body to gradually adapt to Semaglutide. This approach may reduce the likelihood and severity of gastrointestinal side effects such as nausea and vomiting before progressing to higher doses. Individual tolerance, however, may vary.
5. How is Wegovy 0.25mg administered?
Wegovy is intended to be injected subcutaneously (under the skin) once weekly. Common injection sites may include the abdomen, thigh, or upper arm, as guided by your doctor.
6. What does the dose titration schedule look like?
The dose is typically increased gradually every 4 weeks, progressing from 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg (maintenance dose). The titration schedule is designed to improve tolerability and should be followed strictly under your doctor's guidance.
7. What are the possible side effects of Wegovy?
Some patients may experience:
• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Abdominal pain
• Headache
These are often reported during dose escalation and may subside over time. Not all patients will experience these effects.
8. Can Wegovy be considered for patients with Type 2 diabetes?
While a lower-dose Semaglutide formulation (Ozempic) is primarily indicated for Type 2 diabetes management, Wegovy's suitability in patients with both Type 2 diabetes and obesity is a clinical decision that must be made by your physician after assessing the full clinical picture.
9. May Wegovy be effective long-term?
Some clinical trials suggest that sustained weight management may be possible with continued use of Semaglutide over an extended period when combined with lifestyle modifications. However, evidence also indicates that weight may return in some patients if the medication is discontinued. Long-term outcomes vary between individuals.
10. Who should not use Wegovy?
Wegovy may not be suitable for:
• Individuals with a personal or family history of medullary thyroid carcinoma
• Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Those with known hypersensitivity to Semaglutide or any component of the formulation
Your doctor will assess contraindications prior to prescribing.
11. Is Wegovy available in India?
Availability may vary and is subject to local regulatory approvals and supply conditions. Please consult your doctor or a licensed pharmacist for the most current information regarding availability in your region.
12. Is Wegovy a prescription-only medicine?
Yes. Wegovy must be prescribed by a qualified healthcare professional and is not available for purchase over the counter.
Medical Disclaimer:
Wegovy 0.25mg Injection is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.